Concepedia

Kirk A. Staschke

KA

34

Publications

2.6K

Citations

27

H-Index

1994

Active since

Affiliations

Eli Lilly (United States)(Current)

Indiana University School of Medicine

Indiana University – Purdue University Indianapolis

Cleveland Clinic

Indiana University Health

Kirk A. Staschke is an author at Eli Lilly (United States) specializing in medicine, cell biology, and virology.

ORCID

Top concepts

Publications per year

1994–2024

34

Publications

34

The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade

David Schaer, Richard P. Beckmann, Jack Dempsey et al. · Cell Reports · 2018 · 418 citations · Full text

Phosphorylation of eIF2 Directs ATF5 Translational Control in Response to Diverse Stress Conditions

Donghui Zhou, Lakshmi Reddy Palam, Li Jiang et al. · Journal of Biological Chemistry · 2008 · 296 citations · Full text

A critical role for IRAK4 kinase activity in Toll-like receptor–mediated innate immunity

Tae Whan Kim, Kirk A. Staschke, Katarzyna Bulek et al. · The Journal of Experimental Medicine · 2007 · 261 citations · Full text

Oligomerization and Cooperative RNA Synthesis Activity of Hepatitis C Virus RNA-Dependent RNA Polymerase

Q. May Wang, Michelle A. Hockman, Kirk A. Staschke et al. · Journal of Virology · 2002 · 138 citations · Full text

Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets

Ying Chen, Jeremy McGee, Xian‐Ming Chen et al. · PLoS ONE · 2014 · 135 citations · Full text

Rows per page

1–5 of 34